Tag Archives: SRNE

Top 10 Clean Energy Stocks To Own For 2018

Some investors are ready to write the obituary for the market phenomenon known as risk on, risk off. Long-suffering stock pickers might be tempted to do some grave dancing.

Risk on, risk off, known by the unfortunate acronym, RORO, was a dominant feature of financial markets in the aftermath of the 2008-2009 crisis. It meant that assets perceived as risky, such as stocks, commodities, and nongovernment bonds, tended to either rally or sell off in lockstep. Assets perceived as safe tended to do the same, but in the opposite direction.

Top 10 Clean Energy Stocks To Own For 2018: First Commonwealth Financial Corporation(FCF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The last year Netflix generated positive free cash flow (FCF), was 2010, which happens to coincide with the year it began significantly increasing its content library, per Figure 2 above. Since then, Netflix has burned through cumulative $3.6 billion in cash, per Figure 3, and the cash burn is only accelerating. In 2015, NFLX’s FCF sat at -$1.6 billion, and over the last twelve months, FCF has worsened to -$1.9 billion.

Top 10 Clean Energy Stocks To Own For 2018: Renewable Energy Group, Inc.(REGI)

Advisors’ Opinion:

  • [By Manikandan Raman]

    There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).

Top 10 Clean Energy Stocks To Own For 2018: Scorpio Tankers Inc.(STNG)

Advisors’ Opinion:

  • [By William Romov]

    Pyxis is a Greece-based liquid fuel transporter operating a fleet of six double-hull tankers in the United States. There was no recent news from the company or analyst revisions that sparked the stocks surge. But some analysts suspect the recent $90 million share offering from Scorpio Tankers Inc. (NYSE: STNG) attracted unusually high speculation in the sector.

  • [By Paul Ausick]

    Scorpio Tankers Inc. (NYSE: STNG) dropped 4.9% Wednesday to post a new 52-week low of $3.10 after closing at $3.26 on Tuesday. The stock’s 52-week high is $4.93. Volume of around 13 million was nearly four times the daily average. The company announced this morning that it had priced an underwritten offering of 30 million shares at $3.00 a share.

  • [By Paul Ausick]

    Scorpio Tankers Inc. (NYSE: STNG) dropped 1 cent Monday to post a new 52-week low of $3.06 after closing at $3.07 on Friday. The stock’s 52-week high is $4.93. Volume of around 4.2 million about 5% above the daily average. The shipping firm priced a secondary offering of 30 million shares at $3.00 a share late last week.

Top 10 Clean Energy Stocks To Own For 2018: Avanir Pharmaceuticals Inc(AVNR)

Advisors’ Opinion:

  • [By Paul Ausick]

    Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analysts upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.

Top 10 Clean Energy Stocks To Own For 2018: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) closed up 10.2% Tuesday following its announcement of solid fourth-quarter earnings after the bell Monday. The company’s 2017 guidance certainly didn’t hurt investors’ confidence either.

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) swung to a profit in the fourth quarter on the back of solid revenue growth and expects to have another productive year in 2017 as the company continues to increase reimbursement for its genetic tests.

Top 10 Clean Energy Stocks To Own For 2018: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Lisa Levin]

    In trading on Friday, non-cyclical consumer goods & services shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Medifast Inc (NYSE: MED), down 5 percent, and Bridgford Foods Corporation (NASDAQ: BRID), down 6 percent.

  • [By Peter Graham]

    A long term performance chart shows small cap weight loss or dieting stocks Weight Watchers International and Reliv International, Inc (NASDAQ: RELV) still underperforming whileNutriSystem Inc (NASDAQ: NTRI) and Medifast Inc (NYSE: MED) began taking off early last year:

  • [By Peter Graham]

    Although obesity is widespread, small cap dieting stocks havetended to causeinvestor portfolios to loose weight. A long term performance chart shows small cap weight loss or dieting stocks Weight Watchers International and Reliv International, Inc (NASDAQ: RELV) stillbelow or at breakeven for longer term investors whileMedifast Inc (NYSE: MED)has performed better and NutriSystem Inc (NASDAQ: NTRI) hasfinally begun to take offearly last year:

Top 10 Clean Energy Stocks To Own For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

Top 10 Clean Energy Stocks To Own For 2018: Sorrento Therapeutics, Inc.(SRNE)

Advisors’ Opinion:

  • [By William Romov]

    San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.

    On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”

Top 10 Clean Energy Stocks To Own For 2018: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Top 10 Clean Energy Stocks To Own For 2018: Archrock, Inc.(AROC)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Company Name

    Share PriceYTDMarket CapClayton Williams Energy Inc. (NYSE: CWEI)$138.8216.4%2.4BDiamondback Energy Inc. (Nasdaq: FANG)$106.365.42%$9.38BWestern Gas Partners LP (NYSE: WES)$65.6411.71%$9.67BTesoro Logistics LP (NYSE: TLLP)$59.3416.79%$6.25BResolute Energy Corp. (NYSE: REN)$46.0811.87%$931.13MAntero Midstream Partners LP (NYSE: AM)$34.9813.28%$6.4BExterran Corp. (NYSE: EXTN)$33.9942.22%$1.19BDominion Midstream Partners LP (NYSE: DM)$32.9011.34%$2.6BNextEra Energy Partners LP (NYSE: NEP)$31.1922.12%$1.68BArchrock Inc. (NYSE: AROC)$16.0021.21%$1.12B

    While some of these stocks have performed well, we arent recommending this list of natural gas stocks. Thats because we arent interested in stocks that have already peaked at Money Morning; were interested in the next big winner. And we have one that could surge in 2017

Best Blue Chip Stocks To Own Right Now

Stocks couldnt shake off early losses and all three major indexes ended lower on Thursday.

Bloomberg News

The Dow Jones Industrial Average lost 210.79 points, or 1.17%, to 17830.76. The S&P 500 Index fell 19.34 points, or 0.92%, to 2075.81. The Nasdaq slid 57.85 points, or 1.19%, to 4805.29.

Blue chips were dragged down by Apple(AAPL): Just days after its disappointing earnings, billionaire Carl Icahn said he no longer has a stake in the stock.

From a data standpoint, First quarter gross domestic product grew 0.5%, below economists expectations, overshadowing an upbeat jobs report that saw unemployment fall to a four-decade low.

Stifels Lindsey Piegza writes that this could push out any interest rate hikes:

From a policy standpoint, should the U.S. economy post meaningful improvement between now and June, assuming the Feds concerns surrounding international risks are not reignited, policy makers appear well positioned to announce the second rate hike in less than two months time. Of course, following this mornings disappointing GDP report, its difficult to imagine a marked improvement in the economy over the next two months. More likely, the combination of stagnant economic conditions, a still-restrained consumer, and ongoing concerns regarding risks of contagion from developments abroad whether directly identified in the statement or not will make it increasingly difficult for the Fed to raise rates once in the remaining nine months of 2016, if at all.

Best Blue Chip Stocks To Own Right Now: Harmony Gold Mining Company Limited(HMY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Alex McGuire]

    This list shows the top-performing gold stocks this month, which we’ll be watching in September 2017. While these stocks posted gains in August, we still aren’t recommending them. Instead, we’re going to show you Money Morning Resource Specialist Peter Krauth’s pick for the best gold stock to buy this year…

    Top Gold Stock Share Price August 2017 Gain
    Sibanye Gold Ltd. (NYSE ADR: SBGL) $6.35 +22.9%
    Iamgold Corp. (NYSE: IAG) $6.49 +20%
    Alamos Gold Inc. (NYSE: AGI) $8.17 +15.1%
    Franco Nevada Corp. (NYSE: FNV) $81.20 +11.6%
    Hudbay Minerals Inc. (NYSE: HBM) $8.70 +11.5%
    Gold Fields Ltd. (NYSE ADR: GFI) $4.42 +10.9%
    Randgold Resources Ltd. (Nasdaq ADR: GOLD) $101.90 +9.6%
    Harmony Gold Mining Co. (NYSE ADR: HMY) $1.97 +8.8%
    Agnico Eagle Mines Ltd. (NYSE: AEM) $50.60 +8.4%
    Yamana Gold Inc. (NYSE: AUY) $2.81 +7.9%

    Life-Changing Profits: This investing strategy has racked up 30 triple-digit wins so far this year – and 46 in the last 12 months. To learn how to get in position for the next one, click here now…

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 0.73 percent. Meanwhile, top losers in the sector included Silver Wheaton Corp. (USA) (NYSE: SLW), down 5 percent, and Harmony Gold Mining Co. (ADR) (NYSE: HMY), down 5 percent.

  • [By Lisa Levin]

    In trading on Friday, basic materials shares tumbled by 1.20 percent. Meanwhile, top losers in the sector included McEwen Mining Inc (NYSE: MUX), down 6 percent, and Harmony Gold Mining Co. (ADR) (NYSE: HMY), down 6 percent.

  • [By Lisa Levin]

    On Wednesday, basic materials shares surged by 0.6 percent. Top gainers in the sector included Harmony Gold Mining Co. (ADR) (NYSE: HMY) and Gold Fields Limited (ADR) (NYSE: GFI).

Best Blue Chip Stocks To Own Right Now: Sorrento Therapeutics, Inc.(SRNE)

Advisors’ Opinion:

  • [By William Romov]

    San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.

    On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”

Best Blue Chip Stocks To Own Right Now: Green Brick Partners, Inc.(GRBK)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggestedgoing long on small cap homebuilder stockGreen Brick Partners (NASDAQ: GRBK):

    For Green Brick Partners, we’re mainly feeding off of the hammer-shaped reversal bar from last week. That long-tailed low only had to kiss the 200-day moving average line (green) at $8.45 to kick-start a reversal, and we’ve seen some nice bullish follow-through so far. Ideally we’d like to see a move above the February ceiling around $9.90, but we fear waiting that long could leave us chasing it higher. See, what you can’t see on the chart (because it’s further back) is that GRBK is no stranger to multi-point runups. Based on its past runs, Green Brick Partners could be in the high teens before you even know it.

Week In Review: China Renaissance Sets $7 Billion Goal For New VC/PE Funds, Including Biotech/Health

China Renaissance, a Beijing investment bank and VC/PE investor, plans to expand its investment funds operations, climbing from $3 billion assets under management currently to $10 billion over the next three years. At the moment, the company runs two funds: Huaxing Growth Capital, focused on technology, media and entertainment, and Huaxing Healthcare. The company plans to build up its healthcare/biotechnology investments and add funds for mezzanine debt, hedge funds and other sectors.

MicroPort Scientific (HK: 00853) (OTCPK:MCRPF), a Shanghai medical device maker, will pay $190 million to acquire the cardiac rhythm management business of Italy’s LivaNova (NASDAQ:LIVN). The two companies are already partners. In 2014, MicroPort and LivaNova, then known as Sorin Group, established a $20 million China JV to offer LivaNova’s cardiac rhythm devices in China. Established in 1998, MicroPort aims to provide affordable high-quality medical devices in China and abroad, many of them minimally invasive.

Canada’s Acasti Pharma (NASDAQ:ACST) signed a $133 million non-binding term sheet with an unnamed China pharma for China/Asia rights to its hypertriglyceridemia drug candidate. CaPre, a prescription medication, is a highly concentrated omega-3 phospholipid derived from krill. Acasti believes CaPre is more readily absorbed into the body than competing omega-3 products. Earlier this year, Acasti announced Phase III trials of the candidate, which will use the abbreviated 505(b)(2) pathway for approval in the US.

3D Medicines, a Beijing biopharma, closed a $101 million funding round. 3DMed says its name stands for its three separate oncology technologies: diagnostics, data, and drug development. The company offers next-gen sequencing for early-stage cancer detection, precision medicine diagnosis and innovative drug development. The funding was led by China Reform Holdings (via China State-Owned Assets Venture Investment Fund) and joined by ChinaEquity Group and several unnamed investors.

Beijing’s Immunochina raised $7.5 million to support clinical trials of its CAR-T product for lymphoma. Formed by three PhD graduates from Tsinghua University in 2015, Immunochina has started a Phase II trial of its CAR-T candidate in Acute Lymphocytic Lymphoma patients and a Phase I test in Diffuse Large B-cell Lymphoma. The company expects its CAR-T product will be more effective that US-developed candidates.

Lee’s Pharm (HK: 0950) and Beijing Shenogen Pharma announced a second cancer partnership that involves Shenogen’s icaritin, a small molecule, TCM-derived treatment currently in China Phase III trials for hepatocellular carcinoma. In the latest joint effort, Lee’s Pharm will pair its PD-L1 candidate with icaritin. Lee’s in-licensed China rights to the PD-L1 molecule from San Diego’s Sorrento Therapeutics (NASDAQ:SRNE). One year ago, Lee’s and Shenogen agreed to co-develop a combination of Lee’s Pexa-Vec, an oncolytic virus intended for HCC, and icaritin.

Guangzhou RiboBio signed a strategic partnership agreement with GE Healthcare Life Sciences (NYSE:GE) to build Asia’s largest oligonucleotide drug development and manufacturing facility in China. The partnership plans to provide a complete suite of services for global oligonucleotide drug companies. Founded in 2004, RiboBio offers nucleic acid products and services. In 2013, the company built its first cGMP oligonucleotide manufacturing facility. Oligonucleotide drugs, which target disease-specific genes, are being developed to treat cancer, infectious diseases and genetic diseases.

Disclosure: None

Editor’s Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.

SeekingAlphaAbout this article:ExpandTagged: Investing Ideas, Quick Picks & ListsWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here